chrisvoncsefalvay/vaers-outcomes huggingface dataset:
He reports with his first Typhoid (ViCPS) dose on 2 September 2014 he developed large local swelling within 10-15 minutes that lasted for 1-2 days prior to resolving. He denies generalized cutaneous, constitutional, and systemic symptoms with this dose. He received his second Typhoid dose (booster) on 2 September 2016 while deployed and 5-10 minutes later he developed local itching and swelling which progressed over the next several hours to affect his entire upper extremity and chest. He was anxious due to the worsening swelling and reports feeling that his throat was swelling causing difficulty swallowing. He admits to feeling anxious, possibly panicking, and thinks this may have caused him to have transient shortness of breath. He denies systemic symptoms but had diarrhea for several days after receiving the vaccine. He took Benadryl with resolution of his laryngeal symptoms; the swelling affecting his arm lasted for 3-4 days.
PATIENT DEVELOP A LARGE RED AND SWOLLEN RASH ACCROSS THE SITE OF THE INJECTION AND DOWN HER ARM; PRESRIBED SUSPECTS CELLUTIS AND SENT IN ANTIBIOTICS
Very high blood pressure; Dizziness; Weakness; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HYPERTENSION (Very high blood pressure), DIZZINESS (Dizziness) and ASTHENIA (Weakness) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Glaucoma.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced DIZZINESS (Dizziness) and ASTHENIA (Weakness). On 11-Mar-2021, the patient experienced HYPERTENSION (Very high blood pressure). At the time of the report, HYPERTENSION (Very high blood pressure) outcome was unknown and DIZZINESS (Dizziness) and ASTHENIA (Weakness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took treatment medications for High  Blood pressure.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: Additional TCR form is received which does not contain any new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
During observation client reported feeling nauseous. Assessment revealed no hives, redness, discoloration, swelling, or signs or symptoms of shortness of breath. Client has a history of high blood pressure without prescribed meds, hyperthyroidism and an allergy to penicillin. She reported not having breakfast in the morning and not drinking water. She was given water and vitals were taken at 5 mins intervals and was in observation for an additional 30mins. Her nausea subsided during the additional 30mins of observation. When 30mins of observation were completed a Pfizer fact sheet was given and ER precautions were given as well. Client left site in no apparent distress.
breathing got bad; became sick and was not able to make 2nd Pfizer shot; This is a spontaneous report from a contactable consumer (patient's husband) from a Regulatory Authority CEP 159558.  A 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number: Unknown), via an unspecified route of administration on an unspecified date (reported 3 weeks ago) as dose 1, single for COVID-19 immunization. Medical history included emphysema. Concomitant medications were not reported. On an unspecified date after first dose, patient became sick and was not able to make 2nd Pfizer shot yesterday (date unspecified), because her breathing got bad due to her emphysema. Patient doctor had prescribed her a 6-day course of steroids that she has now taken for 2 days. It was not reported if the patient visited physician office. The events were reported as non-serious. Reporter would like to know if this will effect the shot, when can patient get her 2nd shot, how long does the vaccine last and how long patient needed to wait after finishing the steroids before taking the next dose of the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
I had the Flu shot at clinic on Dec. 9, 2016. Vaccine was given at 11:15 and at 4:30 same day my arm was in extreme pain and not able to move it, up or to the side. It has been in pain for 2 months now. I feel like the shot was given too high on my Left arm, up near my shoulder blade.
The shot hurt when administered, didn't feel the first one. About 2 minutes after shot, felt light headed and like the shot contained adrenalin or epinephrine. That subsided by the time I left the site, although I remained slightly light headed all evening. Went to bed at 10:00 with an extremely sore arm, beginning of body aches and fever of 99.3. Awoke at 1:00am with 101.9 temp, extreme muscle and joint pain, and every time I moved anything, even a finger I would feel the sensation of a chill or slight electric shock. Urinated every hour from 1:00am and 5:00 am. When I awoke at 5:00 I was so weak, nauseated and dripping sweat I barely got my dog fed and let out for the morning. The nausea passed quickly but I thought I was going to have to lie down on the floor during that wave.Went back to bed, slept until 7:00 and was pretty much a zombie until 6:00pm last night(March 10) when all exhaustion and muscle pain disappeared and I have been fine since then.
flush face, neck et ears w/in 3-4min p/vax given;referred to MD inc pulse & resp, BP 130/60;
Shingles; small vesicles; itching; Pain; Erythema; This case was reported by a physician via call center representative and described the occurrence of shingles in a 84-year-old male patient who received Herpes zoster (Shingrix) for an unknown indication.   Concurrent medical conditions included gluten intolerance, allergy to chemicals (Autoimmune disorder as secondary to agent orange), atopic dermatitis and penicillin allergy.   On 29th October 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 30th October 2019, 1 days after receiving Shingrix and an unknown time after starting cortisone acetate and Valtrex, the patient experienced pain and erythema. On an unknown date, the patient experienced shingles, vesicles and pruritus. The patient was treated with cortisone acetate, OPIOIDS {NOS} (OPIOIDS) and valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the shingles, erythema, vesicles and pruritus were not recovered/not resolved and the outcome of the pain was recovering/resolving.   It was unknown if the reporter considered the shingles, pain, erythema, vesicles and pruritus to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix vaccine on the left deltoid and on the next day he the patient developed pain (9 on a scale from 1-10) and a large erythematous area approximately 9 inches in size on his left chest and belt line. In the erythematous area, the patient had small vesicles and intense itching. The doctor suspects that the patient had Shingles. The doctor started the patient on a short course of cortisone, opioids and Valtrex. The patient had experienced partial pain relief. The reporter consented to follow up.      Lab Comments: On an unknown date, lab test was performed for pain which was 9 on a scale from 1 to 10
This is a spontaneous report received from contactable reporter (consumer). The reporter is the parent. A 19 year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) at the age of 19 years as dose number unknown (initial Pfizer dose), single for COVID-19 immunisation. Relevant medical history included: "Type one diabetic" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: COVID-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization. The following information was reported: SEIZURE (medically significant) with onset 06Dec2021, outcome "unknown", described as "Seizure"; EPILEPSY (medically significant), outcome "unknown", described as "epilepsy"; BLOOD GLUCOSE ABNORMAL (non-serious), outcome "unknown", described as "blood sugar was in the 300's". The events were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood glucose abnormal: 300. Additional information: The caller's son is type one diabetic and had his booster. He was in college in November. The patient had a seizure and went to the hospital and his blood sugar was in the 300's so it wasn't related to the blood sugar at all. They went to a neurologist and did the follow up and didn't find anything. The patient can't drive for 6 months. They thought that maybe the patient had epilepsy, so he is on medications to prevent it. Everyone the caller has mentioned are all around the same age. It's such a weird coincidence and the caller decided to called Pfizer. Patient's weight is 180-185. The patient went to the hospital, and they ran tests in the emergency room, but he never stayed overnight. The lot number for BNT162b2 was not provided and will be requested during follow up. Sender's Comments: Linked Report(s): US-PFIZER INC-202200495438 same reporter/drug, similar events, different patients; US-PFIZER INC-202200494202 same reporter/drug, similar events, different patients; US-PFIZER INC-202200494339 same reporter/drug, similar events, different patients.
Information has been received from a physician concerning a 34 month old white female with no pertinent medical history or allergies, who on 30-AUG-2004 in the afternoon was vaccinated with her first dose of varicella virus vaccine live (Oka/Merck) (Lot# 647763/0191P) in the left lower arm. There was no concomitant medication. On 11-JUL-2007 the patient developed shingles involving the left arm. Unspecified medical attention was sought. No labs were performed. Subsequently the patient recovered. There was no product quality complaint. Additional information has been requested.
2 days after vaccination, client became ill with s/sx of "upset stomach, headache, achy, reddening of skin with a flat rash that appeared to be hives". Symptoms were relieved by Benadryl. Client could not eat for 2 days.
The patient did not have an adverse event. However, this 15-year-old accidentally received a Pfizer booster, although it is only approved for age 16+.
positive Covid test approximately 33 days after second shot; positive Covid test approximately 33 days after second shot; dose 1 administered on 09Mar2021; dose 2 administered on 09Mar2021; This is a spontaneous report from a contactable consumer (patient). An adult female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the left arm, on 09Mar2021 (lot number: EN6207), as 2nd dose, single dose; and via an unspecified route of administration, administered in the left arm, on 09Mar2021 13:30 (pending clarification) (lot number: EN6204), as 1st dose, single dose, for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. There was no medical history, no known allergies. The patient's concomitant medications were not reported. On 05May2021 (also reported as "33 days after the second shot"), the patient tested positive in COVID test despite being fully vaccinated and mounting an "amine response" (as reported, pending clarification) after both shots, The patient was extremely ill for two weeks. The events resulted to physician's office visit and was treated with "Pquenil", azithromycin, dexamethasone and ivermectin. The patient underwent lab tests and procedures which included COVID-19 nasal swab: positive on 05May2021. The outcome of the events "positive Covid test approximately 33 days after second shot" and "mounting an amine response" was not recovered.  Follow-up attempts are needed. Further information is expected.
Patient was given Pfizer for dose 2 instead of Moderna. Patient did not have any reported side effects during observation period.
This case was reported by a physician via call center representative and described the occurrence of blurred vision in a patient who received RABAVERT. On an unknown date, the patient received the 3rd dose of RABAVERT. On an unknown date, unknown after receiving RABAVERT, the patient experienced blurred vision, tingling of extremity, weakness generalized and tinnitus. On an unknown date, the outcome of the blurred vision, tingling of extremity, weakness generalized and tinnitus were not recovered/not resolved. It was unknown if the reporter considered the blurred vision, tingling of extremity, weakness generalized and tinnitus to be related to RABAVERT. Additional details were provided as follows: The age at vaccination was not reported. The healthcare provider called to notify that, the patient was receiving post-exposure prophylaxis and reported symptoms of blurred vision, tinnitus, tingling in hands, and slight weakness after 3rd dose of RABAVERT. Emergency room or doctors visit was required. The reporter was unable or unwilling to provide with any additional product or patient information, however he wanted to know how these adverse events were treated in past for the peoples who had previously reported it. The reporter stated that the blurred vision was the primary concern as it was serious.
Cellulitis Narrative:  Patient presented to the ED and reported right arm redness and swelling. This was attributed to the Pneumococcal PPSV23 vaccine. Patient received cephalexin 500for treatment of the non-purulent soft tissue infection and has since resolved.
Pt reports red, swollen induration at injection site, persisting 3 weeks so far. Pruritic, no vesicles.
Patient had already left after realizing the medication was not reconstituted with diluent. Patient's mother was called by Dr. to inform them of the error and potential side effects. She told Mom that the patient was able to take tylenol or ibuprofen if needed. The patient was not experiencing any reactions at that time. Patient's mother was contacted again on 05/27/2022 and she stated that the patient was picked up from school today complaining of headache, nausea and swelling at the of site of administration. He was taken to Hospital for evaluation where they administered Zofran and ibuprofen.
home sick with the flu; Initial information received on 14-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-healthcare professional.  This case is linked to case 2020SA291094 (same reporter).  This case involves a female patient of unknown age who was home sick with the flu (influenza), while she received vaccine influenza vaccine.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medication was not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (lot number and expiration date not reported) via unknown route in unknown administration site for prophylaxis vaccination.   On an unknown date, 2 days after initiation of suspect vaccine therapy, the patient was home sick with the flu (influenza).   No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Vomited 5 times 7 hours after receiving the vaccine. No blood from vomiting.; This is a spontaneous report from a contactable consumer (patient herself). A 20-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6206), via an unspecified route of administration in right arm on 06Mar2021 at 16:30 (at the age of 20-year-old) as a single dose for COVID-19 immunization. The patient's medical history included known allergies: allergic to dust and pollen. Concomitant medications were not reported. The patient did not receive other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. On 06Mar2021 at 23:00, the patient experienced vomited 5 times 7 hours after receiving the vaccine. No blood from vomiting. The outcome of the event was recovered on an unspecified date in 2021.   No follow-up attempts are possible. No further information is expected.
gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date; gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date) and PRODUCT STORAGE ERROR (gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047821A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date) and PRODUCT STORAGE ERROR (gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date). On 19-May-2021, EXPIRED PRODUCT ADMINISTERED (gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date) and PRODUCT STORAGE ERROR (gave Moderna Covid-19 Vaccines that were beyond the 30 day refrigeration use by date/10 doses administered past the 30 day use by date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not reported.    Most recent FOLLOW-UP information incorporated above includes: On 13-Oct-2021: Dose administration date added
Tinnitus in right ear Partial hearing loss  Feeling of fullness in right ear Fatigue
I developed a severe case of hives at the vaccine site 5 days after the inoculation. I also had arm pain. Then I developed brain fog, hallucinations, shortness of breath, worse a-fib,  body pain , deep depression.
I NOTICED RED BUMPS COVERING MY DAUGHTERS ARMS AND BACK AT BATH TIME. I GAVE HER 2.5 mL OF BENADRYL AND SHE WENT TO BED. UPON WAKING THE NEXT MORNING THE BUMPS HAD SPREAD TO HER FACE, CHEST, STOMACH, GENITALS, AND LEGS.
This spontaneous report as received from a pharmacist refers to an approximately 67 year old female patient. No information about medical history, concurrent conditions and concomitant medications were reported. The reporter stated that on 07-JUL-2014 the patient was vaccinated with ZOSTAVAX route subcutaneous (dose strength not reported) for vaccination. The patient reported to the pharmacist that on 09-JUL-2014, the patient experienced rash around the injection site. The outcome of rash around the injection site was reported as not recovered/not resolved. No product quality complaint was involved. Additional information has been requested.
She had a lot of pain that started the night of the dose, which is now gone. However, now she has redness which is hot to the touch and extends from point of vaccine down to the elbow.
I received my first vaccine dose on 8/14/2021. Started getting COVID symptoms on 8/20/2021 after being exposed on 8/16/2021. Recovered from COVID by 8/27/2021. Received second COVID vaccine dose on 9/11/2021. On 10/7/2021, I noticed a single round rash on abdomen similar looking to ringworm. After two days, more spots started to show up so I started self-treating with over the counter ringworm cream. Scheduled doctor's appointment for 10/14/2021 after rash had spread all over abdomen, back, arms, the back of thighs, and neck. Diagnosed with pityriasis rosea and not given any medicine or treatment. I was told the rash would go away after a while.
Patient presented today (2/3) with swelling and redness around the right eye. Patient also had a red spot on face below right eye!
Shortly after receiving vaccine, patient reported tightness in chest, difficulty breathing, numbness in arm and headache.  EMS were called and patient was transported further evaluation
Within 4 hours, swelling, redness and discomfort noted left upper extremity. Also noted entire body ached plus headache. Bedridden on second day. Second day redness less, swelling into left breast. Third day swelling less, discomfort at left axilla, body ache only shoulders, neck and headache.
next day developed body aches, extreme fatigue, headache. Injection site arm had redness, swelling and hot to touch from injection site down to elbow that lasted about 4/5 days.
Rash on face, neck and legs, less than 24 hours, post vax. Took Benadryl (po).
knot and redness at the injection site (right arm); knot and redness at the injection site (right arm); It was extremely itchy; required icing to bring down the swelling and to make it feel less hot.; required icing to bring down the swelling and to make it feel less hot.; This is a spontaneous report from a non-contactable consumer (patient). A non-pregnant 68-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in right arm on an unspecified date in Feb2021 (Batch/Lot Number: EN6198), at the age of 68 years old, as dose 2, single for covid-19 immunisation. Medical history included Type II diabetes, known allergies: sulpha drugs, shellfish. No COVID prior to vaccination and was not tested for COVID post vaccination. The patient's concomitant medications were not reported. No other vaccines in four weeks. The patient previously received dose 1 of BNT162B2 administered in left arm in Feb2021 10:45, at the age of 68 years old, for covid-19 immunisation, codeine and experienced allergy/bad reaction. On an unspecified date in Feb2021, the patient had a knot and redness at the injection site (right arm), which lasted for a week. It was extremely itchy and required icing to bring down the swelling and to make it feel less hot. The patient recovered from the events.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a healthcare worker and refers to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX, lot # K021487, expiration date 03-NOV-2016 (dose, route of administration and indication were not reported). Concomitant therapy was not provided. No adverse effects were reported. Additional information has been requested.